Concentrix (NASDAQ: CNXC) releases Q3 2025 financial results press

Rhea-AI Filing Summary

Concentrix Corporation filed a current report stating that it has released its financial results for the third quarter ended August 31, 2025. The company issued a press release on September 25, 2025 to share details about its operations and financial condition for the period.

The press release is included as an exhibit to the report and is incorporated by reference into the results section, giving investors and analysts a central source for the company’s latest quarterly performance information.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001803599FALSE00018035992025-09-262025-09-26

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): September 25, 2025

CONCENTRIX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware			001-39494			27-1605762
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)

39899 Balentine Drive, Suite 235, Newark, California						94560
(Address of principal executive offices)						(Zip Code)

(800) 747-0583

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.0001 per share			CNXC			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Item 2.02.    Results of Operations and Financial Condition.

On September 25, 2025, Concentrix Corporation (the “Company” or “Concentrix”) issued a press release reporting its financial results for the third quarter ended August 31, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference.

The information contained in this Current Report on Form 8-K is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any Concentrix filing or report with the Securities and Exchange Commission, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing or report.

Item 9.01    Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Press release issued by Concentrix Corporation on September 25, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 25, 2025			CONCENTRIX CORPORATION
			By:			/s/ Andre Valentine
						Andre Valentine Chief Financial Officer

FAQ

What did Concentrix (CNXC) disclose in this 8-K filing?

Concentrix disclosed that it issued a press release reporting its financial results for the third quarter ended August 31, 2025, and furnished that release as an exhibit.

Which period do the latest Concentrix (CNXC) results cover?

The results discussed in this filing cover Concentrix’s third quarter ended August 31, 2025.

When did Concentrix (CNXC) issue its third-quarter 2025 earnings press release?

Concentrix issued its third-quarter 2025 earnings press release on September 25, 2025.

Where can investors find the detailed Q3 2025 results for Concentrix (CNXC)?

The detailed Q3 2025 results are contained in the press release furnished as Exhibit 99.1 to this report.

Is the Concentrix (CNXC) Q3 2025 press release considered filed with the SEC?

The company states the information is furnished under Item 2.02 and is not deemed “filed” for purposes of Section 18 of the Exchange Act, except where specifically incorporated by reference.

Which executive signed this Concentrix (CNXC) 8-K?

The report was signed on behalf of Concentrix Corporation by Andre Valentine, the company’s Chief Financial Officer.